PATENT CLAIM ANALYSIS

Application Number: 16048125
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["558", "070000"]

Abstract:
The present invention provides novel bisphosphonate conjugates, pharmaceutical compositions comprising bisphosphonate conjugates and methods of using such analogs in the treatment of bone cancer, bone-related diseases, bone infection, bone inflammation, and diseases of the soft tissues surrounding bones.

Claim (Index 1):
A bisphosphonate conjugate comprising: or a pharmaceutically acceptable acid addition salt thereof wherein,\n X is O; \n V is O or S; \n Y is a residue of an anti-infective compound in a class selected from the group consisting of fluoroquinolones, lincosamides, oxazolidinones, aminoglycosides, cephalosporins, and glycopeptides; \n R 1  is selected from the group consisting of OH, SH, NH 2 , OZ, SZ, NZ, halogen, and H; \n R 2  is selected from the group consisting of H, Z, and halogen; and \n Z is selected from the group consisting of alkyl, cycloalkyl, aryl, heteroaryl, and NH 2 .

Metadata:
- Claim Count in Document: 5.0
- Percentile: 95.0
- Lexical Diversity: 1.41935
- Patent Class: 558.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14968481', '14063951', '10742453', '12413805', '09833083']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7203771825221301
- 35 USC 102 Novelty (BERT): 0.5587300890594585
- Combined Prediction Score: 0.704212473175863
- Mean Citation Score: 346.898196
- Max Citation Score: 380.09067000000016
- Similarity Product: 338.0645605469907

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test